☆ 4.8 Meeting Abstract

Evolution of prescribing trends for HR+/HER2-metastatic breast cancer (mBC) in a post-CDK4/6i world

CANCER RESEARCH (2021)

Journal

CANCER RESEARCH

Volume 81, Issue 4, Pages -

Publisher

AMER ASSOC CANCER RESEARCH

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.